Suitability of differently formulated dry powder Newcastle disease vaccines for mass vaccination of poultry
A suitable powder formulation for the incorporation of live Newcastle disease vaccines was developed by spray drying. Dry powders containing a live-attenuated Newcastle disease vaccine (LZ58 strain) and intended for mass vaccination of poultry were prepared by spray drying using mannitol in combinat...
Gespeichert in:
Veröffentlicht in: | European journal of pharmaceutics and biopharmaceutics 2012-04, Vol.80 (3), p.649-656 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 656 |
---|---|
container_issue | 3 |
container_start_page | 649 |
container_title | European journal of pharmaceutics and biopharmaceutics |
container_volume | 80 |
creator | Huyge, Katrien Van Reeth, Kristien De Beer, Thomas Landman, Wil J.M. van Eck, Jo H.H. Remon, Jean Paul Vervaet, Chris |
description | A suitable powder formulation for the incorporation of live Newcastle disease vaccines was developed by spray drying.
Dry powders containing a live-attenuated Newcastle disease vaccine (LZ58 strain) and intended for mass vaccination of poultry were prepared by spray drying using mannitol in combination with trehalose or inositol, polyvinylpyrrolidone (PVP) and/or bovine serum albumin (BSA) as stabilizers. These powders were evaluated for vaccine stabilizing capacity during production and storage (at 6°C and 25°C), moisture content, hygroscopicity and dry powder dispersibility. A mixture design, varying the ratio of mannitol, inositol and BSA, was used to select the stabilizer combination which resulted in the desired powder properties (i.e. good vaccine stability during production and storage, low moisture content and hygroscopicity and good dry dispersibility). Inositol-containing powders had the same vaccine stabilizing capacity as trehalose powders, but were less hygroscopic. Incorporation of BSA enhanced the vaccine stability in the powders compared to PVP-containing formulations. However, increasing the BSA concentration increased the hygroscopicity and reduced the dry dispersibility of the powder. No valid mathematical model could be calculated for vaccine stability during production or storage, but the individual experiments indicated that a formulation combining mannitol, inositol and BSA in a ratio of 73.3:13.3:13.3 (wt/wt) resulted in the lowest vaccine titre loss during production (1.6–2.0 log10 50% egg infectious dose (EID50) and storage at 6°C (max. 0.8 log10 EID50 after 6months) in combination with a low moisture content (1.1–1.4%), low hygroscopicity (1.9–2.1% water uptake at 60% relative humidity) and good dry dispersibility properties. |
doi_str_mv | 10.1016/j.ejpb.2011.11.018 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_927831207</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0939641111003365</els_id><sourcerecordid>927831207</sourcerecordid><originalsourceid>FETCH-LOGICAL-c462t-ba9f3643c486d7c8c509142184e0f782099cb5a63dbc2ac525eac89752f066993</originalsourceid><addsrcrecordid>eNp9kUtrFUEQhRsxmJvoH3AhsxHdzLUf0y9wE4LGQEgW6rrp6amGvs7L7p6E-ff2cK-6CxQUFN85VdRB6C3Be4KJ-HTYw2Fu9xQTsi-FiXqBdkRJVrOmIS_RDmuma9EQco4uUjpgjBvJ1St0TinhXAq2Q7--LyHbNvQhr9Xkqy54DxHG3K-Vn-Kw9DZDV3VxrebpqYNY3cOTsyn3UNgENkH1aJ0LI6RNUA02pdPE5jCNm-k8LX2O62t05m2f4M2pX6KfX7_8uP5W3z3c3F5f3dWuETTXrdWeiYa5RolOOuU41qShRDWAvVQUa-1abgXrWket45SDdUpLTj0WQmt2iT4cfec4_V4gZTOE5KDv7QjTkoymUjFCsSzkx2dJophkWDDMCkqPqItTShG8mWMYbFwNwWaLwxzMFofZ4jClShxF9O7kv7QDdP8kf_9fgPcnwCZnex_t6EL6z3FZVmNcuM9HDsrfHgNEk1yA0UEXIrhsuik8d8cfwvOpWw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1837306303</pqid></control><display><type>article</type><title>Suitability of differently formulated dry powder Newcastle disease vaccines for mass vaccination of poultry</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Huyge, Katrien ; Van Reeth, Kristien ; De Beer, Thomas ; Landman, Wil J.M. ; van Eck, Jo H.H. ; Remon, Jean Paul ; Vervaet, Chris</creator><creatorcontrib>Huyge, Katrien ; Van Reeth, Kristien ; De Beer, Thomas ; Landman, Wil J.M. ; van Eck, Jo H.H. ; Remon, Jean Paul ; Vervaet, Chris</creatorcontrib><description>A suitable powder formulation for the incorporation of live Newcastle disease vaccines was developed by spray drying.
Dry powders containing a live-attenuated Newcastle disease vaccine (LZ58 strain) and intended for mass vaccination of poultry were prepared by spray drying using mannitol in combination with trehalose or inositol, polyvinylpyrrolidone (PVP) and/or bovine serum albumin (BSA) as stabilizers. These powders were evaluated for vaccine stabilizing capacity during production and storage (at 6°C and 25°C), moisture content, hygroscopicity and dry powder dispersibility. A mixture design, varying the ratio of mannitol, inositol and BSA, was used to select the stabilizer combination which resulted in the desired powder properties (i.e. good vaccine stability during production and storage, low moisture content and hygroscopicity and good dry dispersibility). Inositol-containing powders had the same vaccine stabilizing capacity as trehalose powders, but were less hygroscopic. Incorporation of BSA enhanced the vaccine stability in the powders compared to PVP-containing formulations. However, increasing the BSA concentration increased the hygroscopicity and reduced the dry dispersibility of the powder. No valid mathematical model could be calculated for vaccine stability during production or storage, but the individual experiments indicated that a formulation combining mannitol, inositol and BSA in a ratio of 73.3:13.3:13.3 (wt/wt) resulted in the lowest vaccine titre loss during production (1.6–2.0 log10 50% egg infectious dose (EID50) and storage at 6°C (max. 0.8 log10 EID50 after 6months) in combination with a low moisture content (1.1–1.4%), low hygroscopicity (1.9–2.1% water uptake at 60% relative humidity) and good dry dispersibility properties.</description><identifier>ISSN: 0939-6411</identifier><identifier>EISSN: 1873-3441</identifier><identifier>DOI: 10.1016/j.ejpb.2011.11.018</identifier><identifier>PMID: 22155763</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Administration, Inhalation ; Animals ; Biological and medical sciences ; Cattle ; Chemistry, Pharmaceutical - methods ; Desiccation - methods ; Drug Design ; Drug Stability ; Drug Storage ; Dry Powder Inhalers - methods ; Dry powder vaccine ; Excipients - chemistry ; General pharmacology ; Humidity ; Inositol - chemistry ; Live-attenuated vaccine ; Mannitol ; Mannitol - chemistry ; Mass poultry vaccination ; Mass Vaccination - methods ; Medical sciences ; Newcastle disease ; Newcastle Disease - immunology ; Newcastle Disease - prevention & control ; Newcastle disease virus - chemistry ; Newcastle disease virus - immunology ; Particle Size ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Poultry ; Povidone - chemistry ; Powders - chemistry ; Serum Albumin, Bovine ; Spray drying ; Trehalose - chemistry ; Viral Vaccines - chemistry ; Viral Vaccines - immunology ; Wettability</subject><ispartof>European journal of pharmaceutics and biopharmaceutics, 2012-04, Vol.80 (3), p.649-656</ispartof><rights>2011 Elsevier B.V.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c462t-ba9f3643c486d7c8c509142184e0f782099cb5a63dbc2ac525eac89752f066993</citedby><cites>FETCH-LOGICAL-c462t-ba9f3643c486d7c8c509142184e0f782099cb5a63dbc2ac525eac89752f066993</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejpb.2011.11.018$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25703300$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22155763$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Huyge, Katrien</creatorcontrib><creatorcontrib>Van Reeth, Kristien</creatorcontrib><creatorcontrib>De Beer, Thomas</creatorcontrib><creatorcontrib>Landman, Wil J.M.</creatorcontrib><creatorcontrib>van Eck, Jo H.H.</creatorcontrib><creatorcontrib>Remon, Jean Paul</creatorcontrib><creatorcontrib>Vervaet, Chris</creatorcontrib><title>Suitability of differently formulated dry powder Newcastle disease vaccines for mass vaccination of poultry</title><title>European journal of pharmaceutics and biopharmaceutics</title><addtitle>Eur J Pharm Biopharm</addtitle><description>A suitable powder formulation for the incorporation of live Newcastle disease vaccines was developed by spray drying.
Dry powders containing a live-attenuated Newcastle disease vaccine (LZ58 strain) and intended for mass vaccination of poultry were prepared by spray drying using mannitol in combination with trehalose or inositol, polyvinylpyrrolidone (PVP) and/or bovine serum albumin (BSA) as stabilizers. These powders were evaluated for vaccine stabilizing capacity during production and storage (at 6°C and 25°C), moisture content, hygroscopicity and dry powder dispersibility. A mixture design, varying the ratio of mannitol, inositol and BSA, was used to select the stabilizer combination which resulted in the desired powder properties (i.e. good vaccine stability during production and storage, low moisture content and hygroscopicity and good dry dispersibility). Inositol-containing powders had the same vaccine stabilizing capacity as trehalose powders, but were less hygroscopic. Incorporation of BSA enhanced the vaccine stability in the powders compared to PVP-containing formulations. However, increasing the BSA concentration increased the hygroscopicity and reduced the dry dispersibility of the powder. No valid mathematical model could be calculated for vaccine stability during production or storage, but the individual experiments indicated that a formulation combining mannitol, inositol and BSA in a ratio of 73.3:13.3:13.3 (wt/wt) resulted in the lowest vaccine titre loss during production (1.6–2.0 log10 50% egg infectious dose (EID50) and storage at 6°C (max. 0.8 log10 EID50 after 6months) in combination with a low moisture content (1.1–1.4%), low hygroscopicity (1.9–2.1% water uptake at 60% relative humidity) and good dry dispersibility properties.</description><subject>Administration, Inhalation</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Cattle</subject><subject>Chemistry, Pharmaceutical - methods</subject><subject>Desiccation - methods</subject><subject>Drug Design</subject><subject>Drug Stability</subject><subject>Drug Storage</subject><subject>Dry Powder Inhalers - methods</subject><subject>Dry powder vaccine</subject><subject>Excipients - chemistry</subject><subject>General pharmacology</subject><subject>Humidity</subject><subject>Inositol - chemistry</subject><subject>Live-attenuated vaccine</subject><subject>Mannitol</subject><subject>Mannitol - chemistry</subject><subject>Mass poultry vaccination</subject><subject>Mass Vaccination - methods</subject><subject>Medical sciences</subject><subject>Newcastle disease</subject><subject>Newcastle Disease - immunology</subject><subject>Newcastle Disease - prevention & control</subject><subject>Newcastle disease virus - chemistry</subject><subject>Newcastle disease virus - immunology</subject><subject>Particle Size</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Poultry</subject><subject>Povidone - chemistry</subject><subject>Powders - chemistry</subject><subject>Serum Albumin, Bovine</subject><subject>Spray drying</subject><subject>Trehalose - chemistry</subject><subject>Viral Vaccines - chemistry</subject><subject>Viral Vaccines - immunology</subject><subject>Wettability</subject><issn>0939-6411</issn><issn>1873-3441</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUtrFUEQhRsxmJvoH3AhsxHdzLUf0y9wE4LGQEgW6rrp6amGvs7L7p6E-ff2cK-6CxQUFN85VdRB6C3Be4KJ-HTYw2Fu9xQTsi-FiXqBdkRJVrOmIS_RDmuma9EQco4uUjpgjBvJ1St0TinhXAq2Q7--LyHbNvQhr9Xkqy54DxHG3K-Vn-Kw9DZDV3VxrebpqYNY3cOTsyn3UNgENkH1aJ0LI6RNUA02pdPE5jCNm-k8LX2O62t05m2f4M2pX6KfX7_8uP5W3z3c3F5f3dWuETTXrdWeiYa5RolOOuU41qShRDWAvVQUa-1abgXrWket45SDdUpLTj0WQmt2iT4cfec4_V4gZTOE5KDv7QjTkoymUjFCsSzkx2dJophkWDDMCkqPqItTShG8mWMYbFwNwWaLwxzMFofZ4jClShxF9O7kv7QDdP8kf_9fgPcnwCZnex_t6EL6z3FZVmNcuM9HDsrfHgNEk1yA0UEXIrhsuik8d8cfwvOpWw</recordid><startdate>20120401</startdate><enddate>20120401</enddate><creator>Huyge, Katrien</creator><creator>Van Reeth, Kristien</creator><creator>De Beer, Thomas</creator><creator>Landman, Wil J.M.</creator><creator>van Eck, Jo H.H.</creator><creator>Remon, Jean Paul</creator><creator>Vervaet, Chris</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>20120401</creationdate><title>Suitability of differently formulated dry powder Newcastle disease vaccines for mass vaccination of poultry</title><author>Huyge, Katrien ; Van Reeth, Kristien ; De Beer, Thomas ; Landman, Wil J.M. ; van Eck, Jo H.H. ; Remon, Jean Paul ; Vervaet, Chris</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c462t-ba9f3643c486d7c8c509142184e0f782099cb5a63dbc2ac525eac89752f066993</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Administration, Inhalation</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Cattle</topic><topic>Chemistry, Pharmaceutical - methods</topic><topic>Desiccation - methods</topic><topic>Drug Design</topic><topic>Drug Stability</topic><topic>Drug Storage</topic><topic>Dry Powder Inhalers - methods</topic><topic>Dry powder vaccine</topic><topic>Excipients - chemistry</topic><topic>General pharmacology</topic><topic>Humidity</topic><topic>Inositol - chemistry</topic><topic>Live-attenuated vaccine</topic><topic>Mannitol</topic><topic>Mannitol - chemistry</topic><topic>Mass poultry vaccination</topic><topic>Mass Vaccination - methods</topic><topic>Medical sciences</topic><topic>Newcastle disease</topic><topic>Newcastle Disease - immunology</topic><topic>Newcastle Disease - prevention & control</topic><topic>Newcastle disease virus - chemistry</topic><topic>Newcastle disease virus - immunology</topic><topic>Particle Size</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Poultry</topic><topic>Povidone - chemistry</topic><topic>Powders - chemistry</topic><topic>Serum Albumin, Bovine</topic><topic>Spray drying</topic><topic>Trehalose - chemistry</topic><topic>Viral Vaccines - chemistry</topic><topic>Viral Vaccines - immunology</topic><topic>Wettability</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huyge, Katrien</creatorcontrib><creatorcontrib>Van Reeth, Kristien</creatorcontrib><creatorcontrib>De Beer, Thomas</creatorcontrib><creatorcontrib>Landman, Wil J.M.</creatorcontrib><creatorcontrib>van Eck, Jo H.H.</creatorcontrib><creatorcontrib>Remon, Jean Paul</creatorcontrib><creatorcontrib>Vervaet, Chris</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmaceutics and biopharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huyge, Katrien</au><au>Van Reeth, Kristien</au><au>De Beer, Thomas</au><au>Landman, Wil J.M.</au><au>van Eck, Jo H.H.</au><au>Remon, Jean Paul</au><au>Vervaet, Chris</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Suitability of differently formulated dry powder Newcastle disease vaccines for mass vaccination of poultry</atitle><jtitle>European journal of pharmaceutics and biopharmaceutics</jtitle><addtitle>Eur J Pharm Biopharm</addtitle><date>2012-04-01</date><risdate>2012</risdate><volume>80</volume><issue>3</issue><spage>649</spage><epage>656</epage><pages>649-656</pages><issn>0939-6411</issn><eissn>1873-3441</eissn><abstract>A suitable powder formulation for the incorporation of live Newcastle disease vaccines was developed by spray drying.
Dry powders containing a live-attenuated Newcastle disease vaccine (LZ58 strain) and intended for mass vaccination of poultry were prepared by spray drying using mannitol in combination with trehalose or inositol, polyvinylpyrrolidone (PVP) and/or bovine serum albumin (BSA) as stabilizers. These powders were evaluated for vaccine stabilizing capacity during production and storage (at 6°C and 25°C), moisture content, hygroscopicity and dry powder dispersibility. A mixture design, varying the ratio of mannitol, inositol and BSA, was used to select the stabilizer combination which resulted in the desired powder properties (i.e. good vaccine stability during production and storage, low moisture content and hygroscopicity and good dry dispersibility). Inositol-containing powders had the same vaccine stabilizing capacity as trehalose powders, but were less hygroscopic. Incorporation of BSA enhanced the vaccine stability in the powders compared to PVP-containing formulations. However, increasing the BSA concentration increased the hygroscopicity and reduced the dry dispersibility of the powder. No valid mathematical model could be calculated for vaccine stability during production or storage, but the individual experiments indicated that a formulation combining mannitol, inositol and BSA in a ratio of 73.3:13.3:13.3 (wt/wt) resulted in the lowest vaccine titre loss during production (1.6–2.0 log10 50% egg infectious dose (EID50) and storage at 6°C (max. 0.8 log10 EID50 after 6months) in combination with a low moisture content (1.1–1.4%), low hygroscopicity (1.9–2.1% water uptake at 60% relative humidity) and good dry dispersibility properties.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>22155763</pmid><doi>10.1016/j.ejpb.2011.11.018</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0939-6411 |
ispartof | European journal of pharmaceutics and biopharmaceutics, 2012-04, Vol.80 (3), p.649-656 |
issn | 0939-6411 1873-3441 |
language | eng |
recordid | cdi_proquest_miscellaneous_927831207 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Administration, Inhalation Animals Biological and medical sciences Cattle Chemistry, Pharmaceutical - methods Desiccation - methods Drug Design Drug Stability Drug Storage Dry Powder Inhalers - methods Dry powder vaccine Excipients - chemistry General pharmacology Humidity Inositol - chemistry Live-attenuated vaccine Mannitol Mannitol - chemistry Mass poultry vaccination Mass Vaccination - methods Medical sciences Newcastle disease Newcastle Disease - immunology Newcastle Disease - prevention & control Newcastle disease virus - chemistry Newcastle disease virus - immunology Particle Size Pharmaceutical technology. Pharmaceutical industry Pharmacology. Drug treatments Poultry Povidone - chemistry Powders - chemistry Serum Albumin, Bovine Spray drying Trehalose - chemistry Viral Vaccines - chemistry Viral Vaccines - immunology Wettability |
title | Suitability of differently formulated dry powder Newcastle disease vaccines for mass vaccination of poultry |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T13%3A57%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Suitability%20of%20differently%20formulated%20dry%20powder%20Newcastle%20disease%20vaccines%20for%20mass%20vaccination%20of%20poultry&rft.jtitle=European%20journal%20of%20pharmaceutics%20and%20biopharmaceutics&rft.au=Huyge,%20Katrien&rft.date=2012-04-01&rft.volume=80&rft.issue=3&rft.spage=649&rft.epage=656&rft.pages=649-656&rft.issn=0939-6411&rft.eissn=1873-3441&rft_id=info:doi/10.1016/j.ejpb.2011.11.018&rft_dat=%3Cproquest_cross%3E927831207%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1837306303&rft_id=info:pmid/22155763&rft_els_id=S0939641111003365&rfr_iscdi=true |